Giuliana Decorti

Author PubWeight™ 45.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial. JAMA 2013 3.67
2 PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 2012 1.66
3 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis. Rheumatol Int 2014 1.41
4 Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res 2008 1.14
5 Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011 1.01
6 Hemolytic effects of water-soluble fullerene derivatives. J Med Chem 2004 0.98
7 Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J Clin Gastroenterol 2011 0.95
8 Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 2003 0.94
9 Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys 2010 0.91
10 Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. Eur J Pharmacol 2004 0.90
11 Fasting increases tobramycin oral absorption in mice. Antimicrob Agents Chemother 2010 0.89
12 Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. Pediatr Blood Cancer 2009 0.89
13 The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011 0.89
14 Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010 0.88
15 ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer. Anticancer Res 2009 0.88
16 Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease. Inflamm Bowel Dis 2007 0.87
17 Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. Br J Clin Pharmacol 2012 0.87
18 Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy. Function of bilitranslocase. FEBS J 2005 0.86
19 Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter. Cardiovasc Res 2010 0.86
20 Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. Gut 2007 0.85
21 Personalized therapies in pediatric inflammatory and autoimmune diseases. Curr Pharm Des 2012 0.85
22 The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1. J Histochem Cytochem 2002 0.85
23 Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient. Int Arch Allergy Immunol 2009 0.83
24 In vitro effects of yessotoxin on a primary culture of rat cardiomyocytes. Toxicol Sci 2008 0.83
25 Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. Front Genet 2013 0.82
26 Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors. Eur J Pediatr 2006 0.82
27 Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability. J Cancer Res Clin Oncol 2010 0.81
28 Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. Int Immunopharmacol 2011 0.81
29 Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease. J Clin Gastroenterol 2014 0.80
30 Bodipy-FL-verapamil: a fluorescent probe for the study of multidrug resistance proteins. Cell Oncol 2004 0.80
31 Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. Cancer Lett 2004 0.80
32 Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. Pharmacogenomics 2012 0.80
33 Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin. Life Sci 2002 0.79
34 Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence. J Crohns Colitis 2010 0.79
35 The effect of clodronate on a mevalonate kinase deficiency cellular model. Inflamm Res 2012 0.79
36 Glutathione-S-transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome. Eur J Clin Pharmacol 2009 0.79
37 Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. Dig Dis Sci 2006 0.79
38 Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. Inflamm Res 2010 0.78
39 Toxicity of Hypericum perforatum (St. John's wort) administered during pregnancy and lactation in rats. Toxicol Appl Pharmacol 2004 0.78
40 Selective resistance to different glucocorticoids in severe autoimmune disorders. Clin Immunol 2009 0.78
41 Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial. Inflamm Bowel Dis 2015 0.77
42 MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. World J Gastroenterol 2013 0.77
43 Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. Dig Dis Sci 2008 0.77
44 Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? Curr Drug Metab 2015 0.75
45 TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. Pharmacogenomics 2014 0.75
46 DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. Pharmacogenomics 2013 0.75
47 St John's wort modulation and developmental expression of multidrug transporters in the rat. Phytother Res 2006 0.75
48 Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics 2013 0.75
49 Inflammatory bowel disease. Lancet 2007 0.75
50 Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. Pharmacogenomics 2013 0.75
51 ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. Pharmacogenomics 2013 0.75
52 Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017 0.75
53 Role of ABC Transporters in the BeWo Trophoblast Cell Line. Toxicol Mech Methods 2008 0.75
54 Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis 2017 0.75
55 Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. Quintessence Int 2013 0.75
56 The effect of nonsurgical periodontal treatment on the severity of drug-induced gingival overgrowth in transplant patients. Quintessence Int 2014 0.75